Mutares SE & Co. KGaA (LON:0UTK)
London · Delayed Price · Currency is GBP · Price in EUR 25.20
-1.10 (-4.18%)
At close: Nov 21, 2025
Mutares SE & Co. KGaA Revenue
In the fiscal year ending September 30, 2025, Mutares SE & Co. KGaA had annual revenue of 7.69B EUR with 44.49% growth.
Revenue
7.69B EUR
Revenue Growth
+44.49%
P/S Ratio
0.09
Revenue / Employee
265.09K EUR
Employees
29,000
Market Cap
474.55M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 7.69B | 2.37B | 44.49% |
| Dec 31, 2024 | 5.32B | -289.80M | -5.17% |
| Sep 30, 2024 | 5.61B | 886.50M | 18.77% |
| Dec 31, 2023 | 4.72B | 956.60M | 25.39% |
| Dec 31, 2022 | 3.77B | 1.25B | 49.64% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |